Role of Chemo with Pancreatic cancer: NAPOLI-3, FOOTPATH, PREOPANC-1 and NORPACT-1 Clinical Trials

The NAPOLI-1 Trial in Pancreatic CancerПодробнее

Comment: Improved 2 year survival for pancreatic cancer with pre-operative chemoradiationПодробнее

Dr. Simeone on Impact of PARP Inhibitors on Pancreatic CancerПодробнее

Pancreatic cancer clinical trial for patients with early stage diseaseПодробнее

Current and Future Directions in Metastatic Pancreatic CancerПодробнее

Clinical Trial PANC-001 VideoПодробнее

Dr. Picozzi on Prognostic Value of Pathologic Response to Chemo in Pancreatic CancerПодробнее

Role of Chemoradiation in Resectable Pancreatic CancerПодробнее

Pancreatic Cancer Clinical Trials NYC | Weill Cornell Medicine Gastrointestinal Oncology ProgramПодробнее

Episode 1 | Understanding Pancreatic CancerПодробнее

Accelerated pancreatic cancer trialsПодробнее

Foods For Pancreatitis | Dr.Kiran Peddi #shortsПодробнее

Dr. Sohal on Eligibility of Patients with Pancreatic Cancer for Clinical TrialsПодробнее

NAPOLI-3: first-line NALIRIFOX in metastatic pancreatic ductal adenocarcinomaПодробнее

Debate: Pre-Op Treatment of Borderline Resectable Pancreatic Cancer - Conventional RTПодробнее

UPMC Clinical Trial, Pancreatic Cancer TreatmentПодробнее

Clinical trials - Are they suitable for everyone with pancreatic cancer?Подробнее

Medical Myth - There is only one kind of pancreatic cancer. 3Подробнее

Empowering Pancreatic Cancer Patients through Clinical TrialsПодробнее